安森美公布第4季度及2021财年业绩实现了创纪录的年度和季度收入、毛利率、利润和现金流

2022年2月8日—安森美（onsemi，美国纳斯达克股票代号：ON）于美国时间2月7日公布了其第4季度及2021财年的业绩，亮点如下：

·创纪录的财年收入67.4亿美元，同比增长28.3%

·创纪录的季度收入18.461亿美元，创纪录的公认会计原则（GAAP）和非GAAP毛利率分别为45.1%和45.2%

·创纪录的季度GAAP和非GAAP运营利润率分别为26.0%和28.6%

·第四季度GAAP和非GAAP摊薄后每股收益分别为0.96美元和1.09美元； 2021年自由现金流同比增长167%，第四季度为4.57亿美元或收入的25%

安森美总裁兼首席执行官（CEO） Hassane El-Khoury说：“我们在2021年纪律严明地执行转型举措，导致了创纪录的财务业绩，并提前实现了我们的财务目标。2021年的收入增长了28.3%。营业收入和自由现金流的增长速度是收入的6倍，因为我们把产品组合集中在电动汽车、先进驾驶辅助系统（ADAS）、替代能源和工业自动化等世俗大趋势上。随着我们将产品组合转向这些高价值的战略市场，我们将继续扩大毛利率，同时增加新产品，合理化我们的制造足迹，并改善我们的整体成本结构。我们的业务前景依然强劲，在我们高度差异化的智能电源和感知产品组合的带动下，我们的设计胜选漏斗同比增长超过60%。就是明证。”

下表概列2021年第4季度与可比较时期的部分财务业绩：

* Convertible Notes， Non-cash Interest Expense is calculated pursuant to FASB’s Accounting Standards Codification Topic 470： Debt.

* Diluted shares outstanding can vary as a result of， among other things， the vesting of restricted stock units， the incremental dilutive shares from the Company‘s convertible senior subordinated notes， and the repurchase or the issuance of stock or convertible notes or the sale of treasury shares. With the adoption of the new accounting standard， the GAAP diluted shares outstanding assumes settling the principal and excess over par value in shares of the Company’s common stock for the 1.625% Notes and only the excess over par value in shares of the Company’s common stock for the 0% Notes， according to the terms of such notes. The non-GAAP diluted shares outstanding includes the shares that are not covered by the Company’s hedge transaction issued concurrently with such notes. In periods when the quarterly average stock price exceeds $30.70 for the 1.625% Notes and $74.34 for the 0% Notes， the dilutive impact of the warrants issued concurrently with such notes are included in the GAAP and non-GAAP diluted shares outstanding. Calculations are based on the Company’s stock price as of December 31， 2021.

** Special items may include： amortization of acquisition-related intangibles; expensing of appraised inventory fair market value step-up; purchased in-process research and development expenses; restructuring， asset impairments and other， net; goodwill impairment charges; gains and losses on debt prepayment; non-cash interest expense; actuarial （gains） losses on pension plans and other pension benefits; and certain other special items， as necessary. These special items are out of our control and could change significantly from period to period. As a result， we are not able to reasonably estimate and separately present the individual impact or probable significance of these special items， and we are similarly unable to provide a reconciliation of the non-GAAP measures. The reconciliation that is unavailable would include a forward-looking income statement， balance sheet and statement of cash flows in accordance with GAAP. For this reason， we use a projected range of the aggregate amount of special items in order to calculate our projected non-GAAP operating expense outlook.

*** We believe these non-GAAP measures provide important supplemental information to investors. We use these measures， together with GAAP measures， for internal managerial purposes and as a means to evaluate period-to-period comparisons. However， we do not， and you should not， rely on non-GAAP financial measures alone as measures of our performance. We believe that non-GAAP financial measures reflect an additional way of viewing aspects of our operations that， when taken together with GAAP results and the reconciliations to corresponding GAAP financial measures that we also provide in our releases， provide a more complete understanding of factors and trends affecting our business. Because non-GAAP financial measures are not standardized， it may not be possible to compare these financial measures with other companies’ non-GAAP financial measures， even if they have similar names.

电话会议

安森美已于美国时间2022年2月7日美国东部时间 （EST）上午9时为金融界举行电话会议，讨论安森美2021年第4季度及全年的业绩。英语电话会议将在公司网站http://www.onsemi.cn的“投资者关系”网页作实时广播。实时网上广播大约1小时后在该网站回放，为时30天。

This document includes “forward-looking statements，” as that term is defined in Section 27A of the Securities Act of 1933， as amended， and Section 21E of the Securities Exchange Act of 1934， as amended. All statements， other than statements of historical facts， included or incorporated in this document could be deemed forward-looking statements， particularly statements about the future financial performance of onsemi， including financial guidance for the year ending December 31， 2021. Forward-looking statements are often characterized by the use of words such as “believes，” “estimates，” “expects，” “projects，” “may，” “will，” “intends，” “plans” or “anticipates” or by discussions of strategy， plans or intentions. All forward-looking statements in this document are made based on our current expectations， forecasts， estimates and assumptions and involve risks， uncertainties and other factors that could cause results or events to differ materially from those expressed in the forward-looking statements. Certain factors that could affect our future results or events are described under Part I， Item 1A “Risk Factors” in the 2020 Annual Report on Form 10-K filed with the Securities and Exchange Commission （“SEC”） on February 16， 2021 （the “2020 Form 10-K”） and from time to time in our other SEC reports. Readers are cautioned not to place undue reliance on forward-looking statements. We assume no obligation to update such information， except as may be required by law. You should carefully consider the trends， risks and uncertainties described in this document， our 2020 Form 10-K and subsequent reports filed with or furnished to the SEC before making any investment decision with respect to our securities. If any of these trends， risks or uncertainties actually occurs or continues， our business， financial condition or operating results could be materially adversely affected， the trading prices of our securities could decline， and you could lose all or part of your investment. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement.